Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
11,64 USD | +0,87% | +2,92% | +43,17% |
Attività
Numero di dipendenti: 557
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Autologous Tumor Infiltrating Lymphocytes
100,0
%
| 0 | nan % | 1 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | nan % | 1 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 30/09/16 |
Director of Finance/CFO | 51 | 14/12/20 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Chief Tech/Sci/R&D Officer | 51 | 18/07/19 | |
Igor Bilinsky
COO | Chief Operating Officer | 51 | 15/03/21 |
Merrill McPeak
BRD | Director/Board Member | 88 | 20/07/11 |
Sara Pellegrino
IRC | Investor Relations Contact | - | - |
Tracy Winton
HRO | Human Resources Officer | - | 01/04/20 |
Raj K. Puri
PRN | Corporate Officer/Principal | - | 01/03/22 |
Jim Ziegler
PRN | Corporate Officer/Principal | - | 01/02/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 20/07/11 |
Director/Board Member | 56 | 07/06/16 | |
Michael Weiser
BRD | Director/Board Member | 61 | 15/03/18 |
Wendy Yarno
BRD | Director/Board Member | 68 | 18/04/23 |
Ryan Maynard
BRD | Director/Board Member | 54 | 16/02/15 |
Iain Dukes
CHM | Chairman | 65 | 01/06/16 |
Director/Board Member | 52 | 10/06/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 0 | 2 842 158 | 0 | 0 | 92,70 % |
Azione B | 0 | 194 | 0 | 0 | |
Azione C | 1 | 278 847 679 | 258 503 652 ( 92,70 %) | 0 |
Coordinate società
Iovance Biotherapeutics, Inc.
825 Industrial Road Suite 400
94070, San Carlos
+650 260 7120
http://www.iovance.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+43,17% | 3,25 Mrd | |
-20,45% | 10,82 Mrd | |
-35,86% | 2,11 Mrd | |
-17,21% | 2,08 Mrd | |
-29,81% | 1,48 Mrd | |
+17,56% | 1,02 Mrd | |
-4,37% | 733 Mln | |
-37,00% | 391 Mln | |
-46,94% | 377 Mln | |
+13,32% | 332 Mln |
- Borsa valori
- Azioni
- Azione IOVA
- Società Iovance Biotherapeutics, Inc.